NextCure reported net income of -$14.89M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 2.30M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.32M | 2.32M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.34M | 2.68M | 2.84M | 5.24M | 5.31M | ||||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 13.60M | 12.26M | 15.02M | 12.82M | 13.53M | 12.82M | 11.65M | 13.45M | 11.01M | 11.83M | 11.40M | 12.42M | 8.77M | 8.90M | 7.90M | 24.09M | 6.14M | 6.80M | 6.83M | 7.42M | ||||||||||||||
| Selling, General & AdministrativeSG&A | 4.91M | 4.81M | 5.75M | 5.30M | 5.71M | 4.95M | 5.42M | 5.71M | 4.61M | 3.96M | 4.36M | 4.08M | 3.73M | 3.55M | 3.73M | 3.20M | 2.81M | 2.96M | 3.27M | 2.59M | ||||||||||||||
| Restructuring CostsRestructuring | 2.54M | 0.50M | 0.37M | 0.31M | 0.32M | 0.29M | 0.33M | 0.41M | 5.08M | |||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.50M | -0.37M | -0.31M | -0.32M | -0.29M | -0.33M | -0.41M | |||||||||||||||||||||||||||
| Operating ExpensesOpex | 18.51M | 17.07M | 20.77M | 18.13M | 19.24M | 17.77M | 17.07M | 19.16M | 15.62M | 15.79M | 18.30M | 16.49M | 12.49M | 12.46M | 11.62M | 27.29M | 8.95M | 9.76M | 10.11M | 15.09M | ||||||||||||||
| Operating IncomeOp. Inc | -18.51M | -17.07M | -20.77M | -18.13M | -19.24M | -17.77M | -17.07M | -19.16M | -15.62M | -15.79M | -18.30M | -16.49M | -12.49M | -12.46M | -11.62M | -27.29M | -8.95M | -9.76M | -10.11M | -15.09M | ||||||||||||||
| EBIT | -18.51M | -17.07M | -20.77M | -18.13M | -19.24M | -17.77M | -17.07M | -19.16M | -15.62M | -15.79M | -18.30M | -16.49M | -12.49M | -12.46M | -11.62M | -27.29M | -8.95M | -9.76M | -10.11M | -15.09M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.07M | -0.53M | -1.54M | -0.14M | -0.06M | 0.90M | 0.69M | -0.12M | 0.32M | 0.38M | 0.04M | 0.10M | 0.16M | -0.07M | -0.00M | -0.01M | 0.02M | 0.00M | -0.02M | -0.00M | ||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.58M | 0.13M | 0.17M | 0.21M | 0.33M | 0.47M | 0.97M | 1.30M | 1.32M | 1.32M | 1.20M | 1.09M | 0.95M | 0.85M | 0.65M | 0.48M | 0.32M | 0.32M | 0.31M | 0.20M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -18.44M | -17.61M | -22.31M | -18.27M | -19.30M | -16.87M | -16.38M | -19.28M | -15.30M | -15.41M | -18.26M | -16.40M | -12.33M | -12.53M | -11.63M | -27.30M | -8.92M | -9.75M | -10.13M | -15.10M | ||||||||||||||
| Profit After TaxPAT | -17.93M | -17.47M | -20.60M | -17.92M | -18.97M | -16.40M | -16.10M | -17.86M | -14.30M | -14.47M | -17.11M | -15.40M | -11.54M | -11.60M | -10.98M | -26.82M | -8.62M | -9.44M | -9.80M | -14.89M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -18.44M | -17.61M | -22.31M | -18.27M | -19.30M | -16.87M | -16.38M | -19.28M | -15.30M | -15.41M | -18.26M | -16.40M | -12.33M | -12.53M | -11.63M | -27.30M | -8.92M | -9.75M | -10.13M | -15.10M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -18.44M | -17.61M | -22.31M | -18.27M | -19.30M | -16.87M | -16.38M | -19.28M | -15.30M | -15.41M | -18.26M | -16.40M | -12.33M | -12.53M | -11.63M | -27.30M | -8.92M | -9.75M | -10.13M | -15.10M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -18.44M | -17.61M | -22.31M | -18.27M | -19.30M | -16.87M | -16.38M | -19.28M | -15.30M | -15.41M | -18.26M | -16.40M | -12.33M | -12.53M | -11.63M | -27.30M | -8.92M | -9.75M | -10.13M | -15.10M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -18.44M | -17.61M | -22.31M | -18.27M | -19.30M | -16.87M | -16.38M | -19.28M | -15.30M | -15.41M | -18.26M | -16.40M | -12.33M | -12.53M | -11.63M | -27.30M | -8.92M | -9.75M | -10.13M | -15.10M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -8.01 | -7.65 | -9.66 | -7.90 | -8.34 | -7.30 | -7.08 | -8.31 | -6.59 | -6.64 | -7.85 | -7.03 | -5.29 | -5.38 | -4.98 | -11.50 | -3.33 | -3.43 | -1.93 | -2.84 | ||||||||||||||
| EPS (Diluted) | -8.01 | -7.65 | -9.66 | -7.90 | -8.34 | -7.30 | -7.08 | -8.31 | -6.59 | -6.64 | -7.85 | -7.03 | -5.29 | -5.38 | -4.98 | -11.50 | -3.33 | -3.43 | -1.93 | -2.84 | ||||||||||||||
| Shares Outstanding | 2.30M | 2.30M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.32M | 2.32M | 2.32M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.37M | 2.68M | 2.84M | 5.24M | 5.31M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 2.30M | 2.30M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.32M | 2.32M | 2.32M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.37M | 2.68M | 2.84M | 5.24M | 5.31M | ||||||||||||||
| EBITDA | -18.51M | -17.07M | -20.77M | -18.13M | -19.24M | -17.77M | -17.07M | -19.16M | -15.62M | -15.79M | -18.30M | -16.49M | -12.49M | -12.46M | -11.62M | -27.29M | -8.95M | -9.76M | -10.11M | -15.09M |